Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Survivin as a target for new anticancer interventions.

Journal of cellular and molecular medicine - 1 Jan 2000

Zaffaroni Nadia, Pennati Marzia, Daidone Maria Grazia

Abstract excerpt

Survivin is a member of the inhibitor of apoptosis protein (IAP) family, that has been implicated in both control of cell division and inhibition of apoptosis. Specifically, its anti-apoptotic function seems to be related to the ability to directly or indirectly inhibit caspases. Survivin is selectively expressed in the most common human neoplasms and appears to be involved in tumor cell resistance to some...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cyclin-Dependent Kinases
Share to Enzyme Inhibitors
Share to Inhibitor of Apoptosis Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Microtubule-Associated Proteins

Share to Oligonucleotides, Antisense

Share to RNA, Catalytic

Share to RNA Interference

Share to Survivin

Source

Open in PubMed Open full text

Identifiers

PMID: 15963255
DOI: 10.1111/j.1582-4934.2005.tb00361.x
PMCID: PMC6740253

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Survivin as a target for new anticancer interventions.PMID 15963255Read ↗

The Role of Survivin for Radiation Oncology: Moving Beyond Apoptosis InhibitionSemantic proximity Read ↗

Survivin Small Molecules Inhibitors: Recent Advances and ChallengesSemantic proximity Read ↗

Investigations of survivin: the past, present and futureSemantic proximity Read ↗

Survivin as a Therapeutic Target for the Treatment of Human CancerSemantic proximity Read ↗

Survivin and Tumorigenesis: Molecular Mechanisms and Therapeutic StrategiesSemantic proximity Read ↗

Survivin study: What is the next wave?Semantic proximity Read ↗

Cancer cells survive with survivinSemantic proximity Read ↗

The role of survivin as a new target of diagnosis and treatment in human cancer.Semantic proximity Read ↗

Recent Advances on Small-Molecule Survivin InhibitorsSemantic proximity Read ↗

Survivin: A molecular biomarker in cancer.Semantic proximity Read ↗

Clinical aspects for survivin: a crucial molecule for targeting drug-resistant cancersSemantic proximity Read ↗

Emerging Importance of Survivin in Stem Cells and Cancer: the Development of New Cancer TherapeuticsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.